Cargando…
The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice
Science has been at the centre of attempts by major industries, including tobacco, chemical, and pharmaceutical, to delay progress in tackling threats to human and planetary health by, inter alia, obscuring industry harms, and opposing regulation. Some aspects of this influence are well documented,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221522/ https://www.ncbi.nlm.nih.gov/pubmed/34161371 http://dx.doi.org/10.1371/journal.pone.0253272 |
_version_ | 1783711340837208064 |
---|---|
author | Legg, Tess Hatchard, Jenny Gilmore, Anna B. |
author_facet | Legg, Tess Hatchard, Jenny Gilmore, Anna B. |
author_sort | Legg, Tess |
collection | PubMed |
description | Science has been at the centre of attempts by major industries, including tobacco, chemical, and pharmaceutical, to delay progress in tackling threats to human and planetary health by, inter alia, obscuring industry harms, and opposing regulation. Some aspects of this influence are well documented, others remain poorly understood, and similarities between industries remain underexplored. This study, therefore, aims to synthesise the literature to develop an evidence-based typology and model of corporate influence on science in order to provide an overview of this multi-faceted phenomenon. We obtained literature examining corporate attempts to influence science and the use of science in policy and practice from: database searches, bibliographies, expert recommendations, and web alerts; using a modified scoping review methodology (n = 68). Through interpretive analysis we developed the Science for Profit Typology and Model. We identified eight corporate sectors repeatedly engaging in activities to influence science, including: manipulation of scientific methods; reshaping of criteria for establishing scientific “proof”; threats against scientists; and clandestine promotion of policy reforms that increase reliance on industry evidence. The typology identifies five macro-level strategies used consistently across the eight industries, comprising 19 meso-level strategies. The model shows how these strategies work to maximise the volume, credibility, reach, and use of industry-favourable science, while minimising these same aspects of industry-unfavourable science. This creates doubt about harms of industry products/practices or efficacy of policies affecting industry; promotes industry-favoured policy responses and industry products as solutions; and legitimises industry’s role as scientific stakeholder. These efforts ultimately serve to weaken policy, prevent litigation, and maximise use of industry products/practices—maximising corporate profitability. We provide an accessible way to understand how and why corporations influence science, demonstrate the need for collective solutions, and discuss changes needed to ensure science works in the public interest. |
format | Online Article Text |
id | pubmed-8221522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-82215222021-07-07 The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice Legg, Tess Hatchard, Jenny Gilmore, Anna B. PLoS One Research Article Science has been at the centre of attempts by major industries, including tobacco, chemical, and pharmaceutical, to delay progress in tackling threats to human and planetary health by, inter alia, obscuring industry harms, and opposing regulation. Some aspects of this influence are well documented, others remain poorly understood, and similarities between industries remain underexplored. This study, therefore, aims to synthesise the literature to develop an evidence-based typology and model of corporate influence on science in order to provide an overview of this multi-faceted phenomenon. We obtained literature examining corporate attempts to influence science and the use of science in policy and practice from: database searches, bibliographies, expert recommendations, and web alerts; using a modified scoping review methodology (n = 68). Through interpretive analysis we developed the Science for Profit Typology and Model. We identified eight corporate sectors repeatedly engaging in activities to influence science, including: manipulation of scientific methods; reshaping of criteria for establishing scientific “proof”; threats against scientists; and clandestine promotion of policy reforms that increase reliance on industry evidence. The typology identifies five macro-level strategies used consistently across the eight industries, comprising 19 meso-level strategies. The model shows how these strategies work to maximise the volume, credibility, reach, and use of industry-favourable science, while minimising these same aspects of industry-unfavourable science. This creates doubt about harms of industry products/practices or efficacy of policies affecting industry; promotes industry-favoured policy responses and industry products as solutions; and legitimises industry’s role as scientific stakeholder. These efforts ultimately serve to weaken policy, prevent litigation, and maximise use of industry products/practices—maximising corporate profitability. We provide an accessible way to understand how and why corporations influence science, demonstrate the need for collective solutions, and discuss changes needed to ensure science works in the public interest. Public Library of Science 2021-06-23 /pmc/articles/PMC8221522/ /pubmed/34161371 http://dx.doi.org/10.1371/journal.pone.0253272 Text en © 2021 Legg et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Legg, Tess Hatchard, Jenny Gilmore, Anna B. The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice |
title | The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice |
title_full | The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice |
title_fullStr | The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice |
title_full_unstemmed | The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice |
title_short | The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice |
title_sort | science for profit model—how and why corporations influence science and the use of science in policy and practice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221522/ https://www.ncbi.nlm.nih.gov/pubmed/34161371 http://dx.doi.org/10.1371/journal.pone.0253272 |
work_keys_str_mv | AT leggtess thescienceforprofitmodelhowandwhycorporationsinfluencescienceandtheuseofscienceinpolicyandpractice AT hatchardjenny thescienceforprofitmodelhowandwhycorporationsinfluencescienceandtheuseofscienceinpolicyandpractice AT gilmoreannab thescienceforprofitmodelhowandwhycorporationsinfluencescienceandtheuseofscienceinpolicyandpractice AT leggtess scienceforprofitmodelhowandwhycorporationsinfluencescienceandtheuseofscienceinpolicyandpractice AT hatchardjenny scienceforprofitmodelhowandwhycorporationsinfluencescienceandtheuseofscienceinpolicyandpractice AT gilmoreannab scienceforprofitmodelhowandwhycorporationsinfluencescienceandtheuseofscienceinpolicyandpractice |